Related references
Note: Only part of the references are listed.Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
Guido Cavaletti et al.
EUROPEAN JOURNAL OF CANCER (2010)
Vitamin E neuroprotection for cisplatin neuropathy A randomized, placebo-controlled trial
A. Pace et al.
NEUROLOGY (2010)
Tubulin: A Target for Antineoplastic Drugs into the Cancer Cells but also in the Peripheral Nervous System
Annalisa Canta et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors
Steven J. Cohen et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature
Andreas A. Argyriou et al.
BLOOD (2008)
A review on oxaliplatin-induced peripheral nerve damage
Andreas A. Argyriou et al.
CANCER TREATMENT REVIEWS (2008)
Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells - A possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition
Marianne S. Poruchynsky et al.
CELL CYCLE (2008)
Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy
Elizabeth K. Joseph et al.
JOURNAL OF PAIN (2008)
Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy
Vinay Chaudhry et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2007)
Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy
A. A. Argyriou et al.
EUROPEAN JOURNAL OF CANCER CARE (2007)
Neuroprotection during chemotherapy - A systematic review
Melanie Walker et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Incidence and characteristics of peripheral neuropathy during oxaliplatin-based chemotherapy for metastatic colon cancer
Andreas A. Argyriou et al.
ACTA ONCOLOGICA (2007)
Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity
G Cavaletti et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2006)
Protective effect of erythropoietin and its carbamylated derivative in experimental cisplatin peripheral neurotoxicity
R Bianchi et al.
CLINICAL CANCER RESEARCH (2006)
Peripheral neuropathy induced by microtubule-stabilizing agents
JJ Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
FH Hausheer et al.
SEMINARS IN ONCOLOGY (2006)
Paclitaxel plus carboplatin-induced peripheral neuropathy - A prospective clinical and electrophysiological study in patients suffering from solid malignancies
AA Argyriou et al.
JOURNAL OF NEUROLOGY (2005)
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine
G Bianchi et al.
EUROPEAN JOURNAL OF CANCER (2005)
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation
G Lauria et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2005)
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AN1424) to prevent chemotherapy induced peripheral neuropathy
ID Davis et al.
CLINICAL CANCER RESEARCH (2005)
Vitamin E for prophylaxis against chemotherapy-induced neuropathy - A randomized controlled trial
AA Argyriou et al.
NEUROLOGY (2005)
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy
G Cavaletti et al.
ANNALS OF ONCOLOGY (2004)
Derivatives of erythropoietin that are tissue protective but not erythropoietic
M Leist et al.
SCIENCE (2004)
Thalidomide sensory neurotoxicity - A clinical and neurophysiologic study
G Cavaletti et al.
NEUROLOGY (2004)
Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale
G Cavaletti et al.
NEUROLOGY (2003)
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy
EA Calhoun et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Measuring the side effects of taxane therapy in oncology - The functional assessment of cancer therapy-taxane (FACT-taxane)
D Cella et al.
CANCER (2003)
Protection against oxaliplatin acute neurosensory toxicity by venlafaxine
JP Durand et al.
ANTI-CANCER DRUGS (2003)
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: A randomized, double-blind, placebo-controlled trial
S Cascinu et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Chemotherapy-induced peripheral neuropathy
S Quasthoff et al.
JOURNAL OF NEUROLOGY (2002)
Share Paper
